Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Miguel Cid Lopez"'
Autor:
Adrian Mosquera-Orgueira, Jose Angel Diaz Arias, Rocio Serrano Martin, Victor Portela Piñeiro, Miguel Cid Lopez, Andres Peleteiro Raindo, Laura Bao Perez, Marta Sonia Gonzalez Perez, Manuel Mateo Perez Encinas, Maximo Francisco Fraga Rodriguez, Juan Carlos Vallejo Llamas, Jose Luis Bello Lopez
Publikováno v:
HemaSphere, Vol 7, p e2637897 (2023)
Externí odkaz:
https://doaj.org/article/fd9332847a1e418ba40e929405d28bee
Autor:
Adrian Mosquera-Orgueira, Jose Angel Diaz Arias, Rocio Serrano Martin, Victor Portela Piñeiro, Andres Peleteiro Raindo, Miguel Cid Lopez, Laura Bao Perez, Marta Sonia Gonzalez Perez, Manuel Mateo Perez Encinas, Maximo Francisco Fraga Rodriguez, Juan Carlos Vallejo Llamas, Jose Luis Bello Lopez
Publikováno v:
HemaSphere, Vol 7, p e681104f (2023)
Externí odkaz:
https://doaj.org/article/57236ee22ecb4d8ea3d02857c3f057bc
Autor:
Victor Portela Piñeiro, Adrian Mosquera-Orgueira, Eugenia Fernandez Mellid, Jose Angel Diaz Arias, Miguel Cid Lopez, Rocio Serrano Martin, Juan Carlos Vallejo Llamas
Publikováno v:
HemaSphere, Vol 7, p e7138007 (2023)
Externí odkaz:
https://doaj.org/article/d3c8d50e4c894094866052dc95711d10
Autor:
Adrián Mosquera Orgueira, Jose Ángel Díaz Arías, Rocio Serrano Martín, Victor Portela Piñeiro, Miguel Cid López, Andrés Peleteiro Raíndo, Laura Bao Pérez, Marta Sonia González Pérez, Manuel Mateo Pérez Encinas, Máximo Francisco Fraga Rodríguez, Juan Carlos Vallejo Llamas, José Luis Bello López
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of aggressive lymphoma. Approximately 60% of fit patients achieve curation with immunochemotherapy, but the remaining patients relapse or have refractory disease, which predicts a short su
Externí odkaz:
https://doaj.org/article/617f5691a8e74047b11c6b9eeaa33179
Autor:
Adrián Mosquera Orgueira, Jose Ángel Díaz Arías, Miguel Cid López, Andrés Peleteiro Raíndo, Alberto López García, Rosanna Abal García, Marta Sonia González Pérez, Beatriz Antelo Rodríguez, Carlos Aliste Santos, Manuel Mateo Pérez Encinas, Máximo Francisco Fraga Rodríguez, José Luis Bello López
Publikováno v:
HemaSphere, Vol 6, Iss 4, p e706 (2022)
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Despite notable therapeutic advances in the last decades, 30%–40% of affected patients develop relapsed or refractory disease that frequently precludes an infamo
Externí odkaz:
https://doaj.org/article/4028d800fdc4470ea9215a7e8ef0f9b9
Autor:
Adrián Mosquera Orgueira, José Ángel Díaz Arias, Miguel Cid López, Andrés Peleteiro Raíndo, Beatriz Antelo Rodríguez, Carlos Aliste Santos, Natalia Alonso Vence, Ángeles Bendaña López, Aitor Abuín Blanco, Laura Bao Pérez, Marta Sonia González Pérez, Manuel Mateo Pérez Encinas, Máximo Francisco Fraga Rodríguez, José Luis Bello López
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Thirty to forty percent of patients with Diffuse Large B-cell Lymphoma (DLBCL) have an adverse clinical evolution. The increased understanding of DLBCL biology has shed light on the clinical evolution of this pathology, leading to
Externí odkaz:
https://doaj.org/article/47def9812b5e4561b9a2ffba19e04710
Autor:
Adrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, Beatriz Antelo Rodríguez, José Ángel Díaz Arias, Roi Ferreiro Ferro, Natalia Alonso Vence, Ángeles Bendaña López, Aitor Abuín Blanco, Laura Bao Pérez, Paula Melero Valentín, Marta Sonia González Pérez, Claudio Cerchione, Giovanni Martinelli, Pau Montesinos Fernández, Manuel Mateo Pérez Encinas, José Luis Bello López
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Externí odkaz:
https://doaj.org/article/7621093bf9e0435ab51db257b2df8022
Autor:
Adrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, Beatriz Antelo Rodríguez, José Ángel Díaz Arias, Roi Ferreiro Ferro, Natalia Alonso Vence, Ángeles Bendaña López, Aitor Abuín Blanco, Laura Bao Pérez, Paula Melero Valentín, Marta Sonia González Pérez, Claudio Cerchione, Giovanni Martinelli, Pau Montesinos Fernández, Manuel Mateo Pérez Encinas, José Luis Bello López
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0274984 (2022)
[This corrects the article DOI: 10.1371/journal.pone.0247093.].
Externí odkaz:
https://doaj.org/article/42399ef075d8404693d2d63bfaccec8b
Autor:
Adrián Mosquera Orgueira, Miguel Cid López, Andrés Peleteiro Raíndo, Aitor Abuín Blanco, Jose Ángel Díaz Arias, Marta Sonia González Pérez, Beatriz Antelo Rodríguez, Laura Bao Pérez, Roi Ferreiro Ferro, Carlos Aliste Santos, Manuel Mateo Pérez Encinas, Máximo Francisco Fraga Rodríguez, Claudio Cerchione, Pablo Mozas, José Luis Bello López
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Follicular Lymphoma (FL) has a 10-year mortality rate of 20%, and this is mostly related to lymphoma progression and transformation to higher grades. In the era of personalized medicine it has become increasingly important to provide patients with an
Externí odkaz:
https://doaj.org/article/946e64e6f3364a31836120ae590b10a7
Autor:
Adrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, José Ángel Díaz Arias, Marta Sonia González Pérez, Beatriz Antelo Rodríguez, Natalia Alonso Vence, Laura Bao Pérez, Roi Ferreiro Ferro, Manuel Albors Ferreiro, Aitor Abuín Blanco, Emilia Fontanes Trabazo, Claudio Cerchione, Giovanni Martinnelli, Pau Montesinos Fernández, Manuel Mateo Pérez Encinas, José Luis Bello López
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Acute Myeloid Leukemia (AML) is a heterogeneous neoplasm characterized by cytogenetic and molecular alterations that drive patient prognosis. Currently established risk stratification guidelines show a moderate predictive accuracy, and newer tools th
Externí odkaz:
https://doaj.org/article/0c2126a43e2b4b08bd36aea5a3a142eb